Cargando…
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
Cholangiocarcinomas are devastating cancers of biliary origin with limited treatment options. It has previously been shown that the endocannabinoid anandamide exerts antiproliferative effects on cholangiocarcinoma independent of any known cannabinoid receptors, and via the stabilization of lipid raf...
Autores principales: | Huang, Li, Ramirez, Jonathan, Frampton, Gabriel A, Golden, Lessie E, Quinn, Matthew A, Pae, Hae Yong, Horvat, Darijana, Liang, Li-jian, DeMorrow, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126905/ https://www.ncbi.nlm.nih.gov/pubmed/21464819 http://dx.doi.org/10.1038/labinvest.2011.62 |
Ejemplares similares
-
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
por: Leyva-Illades, Dinorah, et al.
Publicado: (2013) -
Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents
por: Frampton, Gabriel, et al.
Publicado: (2010) -
GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats
por: Zúñiga-Romero, Ángel, et al.
Publicado: (2022) -
The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015) -
Ginseng Gintonin Contains Ligands for GPR40 and GPR55
por: Cho, Yeon-Jin, et al.
Publicado: (2020)